Related Experiment Video
Updated: Jul 14, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Assessing Knowledge on Gestational Diabetes Mellitus and Child Health
1Oceania University of Medicine; Apia, Samoa.
Insights
Few women in Australia and Samoa understand the long-term risks of gestational diabetes mellitus (GDM) for their children. Increased education is needed to prevent childhood obesity and type II diabetes mellitus (T2DM).
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes mellitus (GDM) is a pregnancy complication increasing risks for maternal and child obesity and type II diabetes mellitus (T2DM).
- Preventing GDM can reduce long-term health issues in children born to affected mothers.
Purpose of the Study:
- To assess awareness of GDM's long-term risks for children among females aged 12-51 in Australia and Samoa.
- To compare knowledge levels between a developed (Australia) and a developing (Samoa) country.
Main Methods:
- Quantitative study conducted from April to November 2021.
- Surveyed 202 females across Australia and Samoa.
- Compared awareness of GDM's long-term child complications.
Main Results:
- Only 15% of Australian females and 34% of Samoan females were aware of GDM's long-term child complications.
- Physicians/midwives were the primary information source (52%).
- Significant knowledge gaps exist regarding GDM's long-term consequences.
Conclusions:
- Inadequate awareness of GDM's long-term effects on children's health in both countries.
- There is a critical need for enhanced GDM education via healthcare providers, social media, and the internet.
- Increased awareness and prevention strategies may lower obesity and T2DM prevalence.
Abstract:
Gestational diabetes mellitus (GDM) is a diagnosis of glucose intolerance during pregnancy. The risk of type II diabetes mellitus (T2DM) and obesity for the child and mother increases when GDM develops. Preventing the development of GDM could help lower the prevalence of obesity and type II diabetes mellitus morbidity rates in children of affected mothers. The purpose of the study was to identify the awareness level of females ages 12 and 51 years, on the long-term risk of obesity and T2DM on their children in Australia and Samoa. This is a quantitative study involving 202 females, from across Australia and Samoa, between April 2021 and November 2021, comparing the level of knowledge between a developing and developed country. In Australia and Samoa, 15% (n=16) and 34% (n=33) of females respectively, were aware of the long-term complications of GDM on their children. These findings indicate that there is inadequate knowledge regarding the long-term consequences associated with GDM on both the risk for T2DM in women and the risk for long-term complications for their children. The greatest source of information in both countries was obtained from physicians or midwives, 52% (n=105). This supports the need for increased education on GDM, through social media, the internet, and community health professionals. By increasing awareness of GDM and implementing preventive strategies, it may be possible to reduce the prevalence of obesity and T2DM in Australia and Samoa.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

